# China Nuokang Bio-Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/china-nuokang-bio-pharmaceutical

- Industry: Pharmaceuticals
- Headquarters: Shenyang, China
- Website: www.nkbp.com
- Total disclosed funding: $17M
- Latest round: Series A (Dec 20, 2007)
- Investors on record: 2

## About

Based in Shenyang, China, and founded in 1997, China Nuokang Bio-Pharmaceutical is a company that focuses on the research and development of bioactive enzymes and self-derived highly effective activating factor drugs in the cardiovascular and hematology fields. In December 2007, China Nuokang Bio-Pharmaceutical raised USD 17 million of Series A financing from HBM Partners and Sequoia Capital.

China Nuokang Bio-Pharmaceutical is mainly engaged in the research and development of pharmaceuticals. The company's core products include thrombin for injection, alprostadil injection, lipoic acid capsules, etc.

The company generates revenue by developing, manufacturing and marketing hematological and cardiovascular products.

## Funding rounds

- Series A, Dec 20, 2007, $17M — Hong Shan, HBM Partners

## Investors

- Hong Shan — Series A
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series A